Product Information
CHOLESTYRAMINE PACKET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.6978 per EA under NDC 67877029860. Its NADAC has been published 224 times since Dec 22, 2021.
Strength
4 g/8.78g
Manufacturer
Ascend Laboratories, LLCNDC
67877029860
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA211856On Market Since
10/20/2021
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE PACKET has been published 224 times since Dec 22, 2021, and over the history we have for it it has declined 43.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6978 per EA |
|---|---|
| All-time high | $1.2760 (Feb 16, 2022) |
| All-time low | $0.5806 (Apr 17, 2024) |
| 52-week high | $0.9390 |
| 52-week low | $0.6834 |
| Median price | $0.8975 |
| Average price | $0.8934 |
| Largest weekly change | +34.2% (Jun 19, 2024) |
| Weeks tracked | 224 |
| Tracking since | Dec 22, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the cholestyramine powder for suspension market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE PACKET, manufactured by Ascend Laboratories, LLC, is $0.6978 per EA (NDC 67877029860), effective Jun 24, 2026.
How has the price of CHOLESTYRAMINE PACKET changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE PACKET has declined 43.5%. It has been tracked across 224 weekly CMS publications since Dec 22, 2021.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE PACKET?
Since Dec 22, 2021, the NADAC for CHOLESTYRAMINE PACKET has ranged from a low of $0.5806 (Apr 17, 2024) to a high of $1.2760 (Feb 16, 2022), with a median of $0.8975 per EA.
Are there cheaper alternatives to CHOLESTYRAMINE PACKET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CHOLESTYRAMINE PACKET, so no direct lower-cost alternative is listed.
Who manufactures CHOLESTYRAMINE PACKET?
CHOLESTYRAMINE PACKET (NDC 67877029860) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification